Investor Relations
GenMark Dx's mission is to become the market leader in providing high value, simple to perform, clinically relevant multiplex molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies.
For investor information, please contact IR@genmarkdx.com.
Annual Reports
Recent Releases
May 10, 2013
GenMark Diagnostics to Present at the Bank of America Merrill Lynch 2013 Healthcare Conference
May 8, 2013
GenMark Diagnostics Reports First Quarter 2013 Results
Events
May 15, 2013 at 2:20 PM PT
Bank of America Merrill Lynch 2013 Healthcare Conference
May 8, 2013 at 1:15 PM PT
GenMark Diagnostics First Quarter Earnings Conference Call
Related Links
Stock Quote
Price:
14.66
Change:
+ 0.66
Day High:
14.71
Day Low:
13.75
Volume:
112,800
NASDAQ
GNMK
4:00 PM ET on May 23, 2013
Delayed at least 20 minutes.
Provided by eSignal.
Provided by eSignal.